In this webinar, we will cover the key steps and considerations involved in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages. Tailored to scientists, management, and business leaders in the pharmaceutical industry and academia, our discussion will navigate the journey from research to commercialization. Drawing from our nanomaterial-specific niche in the CDMO space and 20 years of experience, we will discuss considerations unique to nanomaterials during technology transfer, scale-up, and establishing quality controls. Gain insights from real-world case studies highlighting successful nanoparticle-based therapeutics projects from start to finish.

The interactive Q&A session will provide an opportunity to ask any questions about the scale-up and manufacture of nanomaterials and decision points throughout this process. Join us to discuss key considerations for each step from R&D through manufacturing.

Speaker:

Diana Dehaini, PhD
Project Manager & Technical Sales Scientist, nanoComposix | Fortis Life Sciences